| product_name | (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid |
| CAS_number | Unavailable |
| formula | C20H20N2O2 |
| molar_mass | 320.39 |
| color | Unavailable |
| phase | Unavailable |
| density | Unavailable |
| melting_point | Unavailable |
| boiling_point | Unavailable |
| solubility | Unavailable |
| vapor_pressure | Unavailable |
| pKa | Unavailable |
| logP | Unavailable |
| stability | Unavailable |
| hazard_classification | Unavailable |
What is the primary function of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid?
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid is a compound utilized in pharmaceutical research due to its potential therapeutic
applications. It is commonly studied for its interactions with specific biological targets
and its effects on cellular processes.
How is
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid synthesized?
The synthesis of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid involves several steps, including the combination of precursor molecules under specific
reaction conditions. Detailed protocols for its preparation are available in scientific
literature and research publications.
What are the potential applications of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid in medicine?
Researchers are investigating the use of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid in the development of novel drugs for various conditions, such as cancer, neurological
disorders, and inflammatory diseases. Its molecular structure allows for targeted
interactions with specific biological pathways.
How does
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid exert its pharmacological effects?
The pharmacological effects of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid are primarily mediated by its ability to modulate key signaling pathways in cells. By
binding to specific targets, this compound can influence cellular responses and biochemical
processes, leading to therapeutic outcomes.
What research studies have been conducted
on the use of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid?
Numerous research studies have explored the potential of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid in preclinical and clinical settings. These investigations have focused on its
efficacy, safety, and mechanisms of action, providing valuable insights for drug
development.
Are there any side effects associated with the use of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid?
As with any pharmaceutical compound, the use of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid may be associated with potential side effects. These can vary depending on the dose,
administration route, and individual patient factors. Clinical studies are ongoing to
evaluate its safety profile.
What is the current status of clinical trials involving
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid?
Several clinical trials are investigating the use of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid in patients with various medical conditions. These trials aim to assess its efficacy,
safety, and potential benefits for treating specific diseases. Results from these studies
will inform future therapeutic applications.
What are the prospects for the future
development of
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid as a pharmaceutical agent?
The promising preclinical and clinical data
surrounding
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic
acid suggest that it holds significant potential as a novel therapeutic agent. Further
research and development efforts will likely focus on optimizing its pharmacological
properties and exploring new applications in medicine.
